Last week, Pear Therapeutics announced that MassHealth will reimburse for prescriptions for Pear’s products reSET and reSET-O. The former treats substance use disorder while the latter treats opioid use disorder. Founded in 2013, Pear Therapeutics develops prescription digital therapeutics: or PDTs. The company has successfully received clearance to commercialize three PDTs. The third, other than […]